Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fading lets hope it wasn't a head fake!
$PDSB
News is coming along with 43% HGEN shares floating short. Ultimate Squeeze on tap. Lets hunt down those bears.
Billion dollar Covid-19 drug around the corner.
Deep Pipeline.
170 Million in cash.
World renown partners & management team.
Small float & Large percentage of shares owned by Institutions & Insiders.
Lenzilumab improved the relative likelihood of survival without need for invasive mechanical ventilation (IMV) by 54%, achieving the primary endpoint of the Phase 3 study.
Clinical improvement was observed over and above other treatments, including steroids and/or remdesivir.
Zuma-19 showing 100% ORR. This is HUGE!
$HGEN
$GME
Let’s hold the line at 6.15
anvissa green lights the trials we launch if it doesn’t except we could test $4.00 again. Place your bets!!
$PDSB
Finally!
$PDSB
Chatter is high on multiple stock boards. We the people have the power 43% of the float is short of a sterling company nearing a blockbuster drug. Run by a world renown management team. A wide array of catalyst can drop at any time!
$HGEN
$GME
ZUMA-19 gets FDA approval after phase 2 no other drugs on the market for this indication. Data point read outs are off the charts so far and is safe.
Sonic Boom short squeeze from the stock gods is coming.
HGEN has all the boxes checked. Adding a 43% shares short of the float can bring in a whole new pool of investors. A billion dollar drug weeks away for CV-19 from EUA. They have countries in Asia and Europe ready to go. $100.00 price target is in the cards. With a billion in potential revenue coming down the pipe. Looking for new all time highs in the near future. I love that 55% of the shares are being held by insiders and institutions float is very small.
$HGEN
GME stop Float 27% shorted today HGEN 43% let’s decimate these shorts and show them what time it is. HGEN is one of the heaviest floats shorted on the market today this can go parabolic at a moments notice lots of catalysts and hammers the company is about to drop.
$HGEN
$GME
Short % of Float (Apr 15, 2021) 42.27% Game stop short squeeze in the making book it!
Lenzilumab improved the relative likelihood of survival without need for invasive mechanical ventilation (IMV) by 54%, achieving the primary endpoint of the Phase 3 study
Clinical improvement was observed over and above other treatments, including steroids and/or remdesivir
Zuma-19 showing 100% ORR. People are sleeping on their Car-T technology.
$HGEN
Good Morning I'm ready!
$PDSB
Missed this one had it on my ticker at times. Good call longs!
$BLRX
I strongly believe we are planning a mass funeral for shorts!
The ultimate death of shorts on here! they will be decimated!
HGEN 27.5% short for an agnostic variant treatment for Covid-19 I'm in EUA is coming deals with multiple countries in the works.
HGEN 175 million in Cash
CEO Cameron Durant is the real deal.
Billion dollars in revenue stated by the company that's for 100k vials at 10k what if they produce and sell more market cap under a billion this is a $60.00-80.00 stock conservatively. Possibly 100.00+ HGEN is being looked at by multiple suitors to be acquired Pipeline is next level.
More people diagnosed with COVID in past 2 weeks than in first 6 months of pandemic, WHO says
https://news.yahoo.com/more-covid-19-cases-reported-164416587.html
"Vaccines are part of the answer, but they are not the only answer."
$PDSB
Missed the dip in the 7.90 range yesterday. Good luck longs.
like the short interest here.
$PDSB
Good morning time to drop the hammers!
$PDSB
I'm excited for the future at the same time I want to see Brazilian approval move forward & the trials move forward Working with the Brazilian government is very risky they don't want the vaccine companies to have patent protection in Brazil & they can call a state of emergency & screw over PDSB possibly. And I want to see the ASCO numbers blow everyone away. The last data read out we had earlier in the year was OK the share price actually went down after the data release in February. I hope we have the better mouse trap. There are many T cell platforms like MRKR and HTBX that are near the same market cap range these two companies have slightly higher market capitalization's but have more funding and are further along in trials with oncology than us so time will tell what the science shows and how the company executes. Show me the money
https://www.pdsbiotech.com/investors/news-center/press-releases/press-releases1/113-2021-news/477-iotechnnouncesreliminaryfficacychievementin20210203
$PDSB
Go Time!
$PDSB
Yes! & Cheers to that!
$PDSB
Well Said! I just hope the CV-19 Vaccine in Brazil moves forward & they don't get screwed by the government of Brazil.
$PDSB
Got lucky today bought 6k shares at 45.00 out 75.00 have a few thousand shares riding on the house now. Weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
$BTX
Brazil Senate votes to suspend patent protection on COVID-19 vaccines
https://www.reuters.com/business/healthcare-pharmaceuticals/brazil-senate-votes-suspend-patent-protection-covid-19-vaccines-2021-04-30/
"According to the proposal, patent holders would be obliged to provide authorities with all the information needed to produce COVID-19 vaccines and medicines. Then, if the government were to call a state of emergency, they could be produced locally under a licensing agreement".
"The government of President Jair Bolsonaro has publicly opposed proposals to suspend patent protections, arguing that such a move could endanger talks with vaccine producers".
This doesn't sound good for PDSB
Im starting to get a little nervous about our footprint in Brazil. I wish they picked any other country other than Brazil their government is so unstable. I hope Frank knows what he's doing here. I hope they don't do another stock raise this year was hoping revenue from the Covid Vaccine would come in the next 12-18 months
Lets Go Made a fortune on BTX today and bought more PDSB.
$PDSB
"The stock market is a device for transferring money from the impatient to the patient." -- Warren Buffett.
$PDSB
Development of PDS0203 may offer potential advantages as a
second generation COVID-19 vaccine
May be effective against multiple COVID-19 variants.
Demonstrated induction of killer CD8+ and helper CD4+ T cells that can target less variable
regions of the SARS-CoV-19 virus and may be effective against currently circulating
variants.
May grant long-lasting immunity (up to 10 years Immunity)
Demonstrated induction of long-lasting, virus-specific memory T-cells necessary for
longer term protection.
High potential for safety
PDS0203 is a subunit vaccine, and does not require the use of attenuated viruses,
traditional adjuvants, DNA or RNA. Versamune®-based vaccines have shown no serious or dose limiting reactions.
PDSB PDS0203 Developing a Versamune®-based COVID-19 vaccine candidate with the
goal of promoting CD8+ T-cell responses and neutralizing antibodies.
PDSB PDS0203 Novel COVID-19 vaccine being developed
in Brazil with consortium partners.
I bought NVAX under $10.00 roughly a year ago it ran from 10.00 to a high of $300.00 PDSB has the same type of potential. No Debt 42% of the shares owned institutions & Insiders. A world class management team 132 million market cap today. has multi billion dollar potential. 3 phase 2 Cancer indications with World renown Partners. NIH Cancer MD Anderson Cancer center & MERCK & the country of Brazil to develop a second generation CV-19 Vaccine possible EUA in 2022. Buy hold and lock up your shares. I became a millionaire off my NVAX investment and look to make tens of million on my PDSB investment
MRNA 72 Billion market cap vaccine last about 6 months.
NVAX 19 billion market cap vaccine hasn't been approved yet.
PDSB second generation vaccine CV-19 long last vaccine 130 million market cap. Debt Free 22.2 Million shares 42% owned by Institutions & Insiders.
PDSB April 2021 Biz presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/april/PDSB_Corporate_Overview_-_April_2021.pdf
PDSB Website:
https://www.pdsbiotech.com
$PDSB
PDSB Second Generation CV-19 Vaccine Potential 10 year protection CV-19 vaccine including variants.
Development of PDS0203 - A second generation COVID-19 vaccine that
promotes powerful T-cell responses and neutralizing antibodies.
PDSB Multiple Peer Reviewed papers:
1.Journal for Immuno Therapy of Cancer:
https://jitc.bmj.com/content/8/1/e000612
2.the Journal of Immunology:
https://www.jimmunol.org/content/202/12/3524
PDSB White Paper:
https://pdsbiotech.com/images/pdf/presentation/2021/Whitepaper-2021_v6.pdf
PDSB website:
https://pdsbiotech.com/
PDSB April 2021 Biz presentation:
https://www.pdsbiotech.com/images/pdf/presentation/2021/april/PDSB_Corporate_Overview_-_April_2021-.pdf
PDS Biotech preparing to initiate 3 phase 2 clinical studies for lead candidate PDS0101
PDSB Greater quantity and quality of Versamune®-induced killer T-cells may result in unique ability to eradicate HPV-positive tumors after a single dose Partnered with MERCK NIH CANCER & MD ANDERSON CANCER CENTER !
Potential to treat all types of HPV-cancer: PDS0101 Phase 2 clinical studies address all types of HPV-associated cancers.
Potential to enhance anti-cancer efficacy of various cancer treatments: Combinations with checkpoint inhibitors, chemotherapy and novel therapies may demonstrate Versamune®’s versatility.
Potential applications beyond oncology: Second Generation PDS0203 COVID-19 phase 1/2 trials may demonstrate protection and induce durable T-cell responses against conserved regions of mutating viruses.
Broad potential for additional partnerships: Successful phase 2 studies with PDS0101 and PDS0203 could enable a broad pipeline of Versamune®-based products containing various antigens.
PDSB PIPELINE:
https://www.pdsbiotech.com/pipeline/oncology
https://www.pdsbiotech.com/pipeline/infectious-disease
$PDSB
PDSB Second Generation CV-19 Vaccine will be be worth Billions possibly tens of Billions.
Pdsb this chart is looking spicyyy !!!! Company is about to drop some serious hammers!
International research: Brazilian COVID-19 variant much more transmissible than other strains.
https://medicalxpress.com/news/2021-04-international-brazilian-covid-variant-transmissible.html
Development of PDS0203 may offer potential advantages as a second generation COVID-19 vaccine
May be effective against multiple COVID-19 variants.
Demonstrated induction of killer CD8+ and helper CD4+ T cells that can target less variable regions of the SARS-CoV-19 virus and may be effective against currently circulating variants.
May grant long-lasting immunity. Demonstrated induction of long-lasting, virus-specific memory T-cells necessary for longer term protection.
High potential for safety
PDS0203 is a subunit vaccine, and does not require the use of attenuated viruses, traditional adjuvants, DNA or RNA. Versamune®-based vaccines have shown no serious or dose limiting reactions.
• World Renown Partners: Clinical partnerships with Merck, MD Anderson and National Cancer Institute. Country of Brazil (national CV-19 vaccine for the country of Brazil also other South American countries will have the opportunity to partner with PDSB second generation CV-19 Vaccine.
Phase 3 CV-19 second generation commencing Q4 EUA Emergency Use Authorization could come in 2022. Hundreds of millions of dollars possibly billions in revenue from PDS0203 and other revenue opportunities for its second generation Covid Vaccine in Latin America.
PDSB April 2021 Biz presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/april/PDSB_Corporate_Overview_-_April_2021.pdf
PDSB Website:
https://www.pdsbiotech.com
PDSB Chart is looking Spicy Hot! Double Digits Triple Digits in 2022
https://giphy.com/gifs/8itapp-hungry-hangry-8it-KbAbh6CbK4r5dyaZ4i
$PDSB
PDSB Being invested in a stock move from single digits to triple digits is really cool its coming!
MRNA 72 Billion market cap vaccine last about 6 months.
NVAX 19 billion market cap vaccine hasn't been approved yet.
PDSB second generation vaccine CV-19 long last vaccine 130 million market cap. Debt Free 22.2 Million shares 42% owned by Institutions & Insiders.
PDSB April 2021 Biz presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/april/PDSB_Corporate_Overview_-_April_2021.pdf
PDSB Website:
https://www.pdsbiotech.com
https://www.memecenter.com/fun/906914/weeeeeeeeeee
$PDSB
About to skyrocket get in now or chase it up.
Lifestyle Changer 10-20x ROI potential.
Small float Micro cap can go parabolic at a moments notice.
If you sold your shares recently call the police you have been robbed.
Boomage!!!
Triple digits are coming I rode NVAX from $8.00 over $200.00 PDSB has better technology for Cancer & Infectious Disease.
I made 4000% on my stocks last year. 5500% on my crypto the last 6 months I know what I'm doing.
https://tenor.com/view/rollercoaster-cats-cat-kitties-animals-gif-5894668
$PDSB
Brazil Covid-19 Variant Tears Through South America in Warning to World.
Countries that recently had the spread of Covid-19 under control are now seeing hospitalizations and deaths surge..
WORLD-LATIN AMERICA-Wall Street Journal 3 hours ago.
https://www.wsj.com/articles/brazil-covid-19-variant-spreads-across-south-america-in-warning-to-world-11619611204
People are you ready to rumble.
Lets' slap that ASSK with authority like you mean it.
$PDSB
PDS Biotechnology stock with an ascending breakout watch above 6.02
Primed to continue its upward trajectory.
Wants to goi parabolic. Double digits next!
News Pending.
MRNA 73 Billion market cap vaccine last about 6 months.
NVAX 19 Billion market cap vaccine hasn't been approved yet.
PDSB second generation vaccine CV-19 long last vaccine 130 million market cap. Debt Free 22.2 Million shares 42% owned by Institutions & Insiders.
PDSB April 2021 Biz presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/april/PDSB_Corporate_Overview_-_April_2021.pdf
PDSB Website:
https://www.pdsbiotech.com
$PDSB
Last chance before this skyrockets.
Had a few friends add heavy today when the MM where playing with themselves.
$PDSB
Needs Volume & Positive updates! Let's go!
Undiscovered Gem waking up.
Calm before the storm.
Wants to go parabolic.
Bottomline this is a multibillion dollar market cap in the making.
$PDSB
Getting ready to run hard! One of the biggest bargains in the sector. New 52 week high coming then double digits..
PDSB Debt Free 22.2 million shares 42% held by Institutions & Insiders.
$MRNA 70 Billion market cap
$NVAX 17 Billion market cap Ran from 8:00-300.00 top on CV-19 Vaccine this year PDSB technology is superior to NVAX so is their management team!
$PDSB 125 million market cap (second generation CV-19 national vaccine for Brazil and South America. Cutting edge Oncology & infectious disease pipelines.
PDSB April 2021 Biz presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/april/PDSB_Corporate_Overview_-_April_2021.pdf
PDSB Website:
https://www.pdsbiotech.com
$PDSB
Weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
PDSB Charts is primed for new 52 week highs! Destroy the shorts their about to get REKT
Boomage! Double Digits then $20.00 Plus. I see the angles before they are being played. $100.00 Plus in 2022 EUA probability. for CV-19 second generation Vaccine.
Induced a >10-fold number of highly potent T-cells and eradication of HPV-positive tumors after a single dose in preclinical studies.
Tumor rechallenge at Day 60; complete and sustained cure of cancer.
Overcomes key limitation of immuno-oncology: > 20-fold increase in circulating dual INF-? & Granzyme-b inducing killer T-cells vs. pre-treatment at day 14 led to rapid clearance of lesions*
Initial data suggests Versamune® possesses the key characteristics of a safe and effective immunotherapeutic treatment.
•Induction of high levels of active CD8+ (killer) T-cells
•Induction of high levels of CD4+ (helper) T-cells
•Ability to overcome tumor immune suppression
•Induction of long-term memory CD8+ T-cells
•No dose limiting toxicities
Versamune® has demonstrated the potential for immunological compatibility with a wide array of tumor and pathogenic antigens..
• Today, 4 tumor antigens are being utilized with the Versamune® platform, more than 75 tumor antigens have been identified.
• We are currently progressing two Versamune®-based infectious disease vaccines, one for SARS-COVID-19, and one for universal influenza.
• Versamune®’s unique flexibility means it may work well with a wide range of identified tumor and pathogenic antigens.
• Potential to continuously expand development of Versamune®-based products through partnerships and licensing.
Developing a Versamune®-based Second Generation COVID-19 vaccine candidate with the goal of promoting CD8+ T-cell responses and neutralizing antibodies
Development of PDS0203 may offer potential advantages as a second generation COVID-19 vaccine
May be effective against multiple COVID-19 variants.
Demonstrated induction of killer CD8+ and helper CD4+ T cells that can target less variable regions of the SARS-CoV-19 virus and may be effective against currently circulating variants.
May grant long-lasting immunity
Demonstrated induction of long-lasting, virus-specific memory T-cells necessary for longer term protection.
High potential for safety
PDS0203 is a subunit vaccine, and does not require the use of attenuated viruses, traditional adjuvants, DNA or RNA. Versamune®-based vaccines have shown no serious or dose limiting reactions.
Buy and hold.
1. Defeat the shorts.
2. Watch it leap into double digits soon.
MRNA 65 Billion market cap vaccine last about 6 months.
NVAX 16 billion market cap vaccine hasn't been approved yet.
PDSB second generation vaccine CV-19 long last vaccine 130 million market cap. Debt Free 22.2 Million shares 42% owned by Institutions & Insiders.
PDSB April 2021 Biz presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/april/PDSB_Corporate_Overview_-_April_2021.pdf
PDSB Website:
https://www.pdsbiotech.com
https://www.memecenter.com/fun/906914/weeeeeeeeeee
$PDSB
Cheers to the weekend.
My Spyder senses tells me PDSB drops a juicy PR next week.
Chart looks golden all we need is volume next week.
$PDSB
Buy and hold.
And then keep on accumulating.
$PDSB
CV-19 GLOBAL CASES AT HIGH.
Covid-19 Is Still Raging in Much of the World as Global Cases Hit Record Highs
New variants, pandemic fatigue and easing of lockdowns have virus surging in many countries.
https://www.wsj.com/articles/covid-19-is-still-raging-in-much-of-the-world-as-global-cases-hit-record-highs-11619185387
PDSB Noble conference this week
https://register.gotowebinar.com/recording/recordingView?webinarKey=908247595350942222®istrantEmail=mrpsimon%40icloud.com
Brazil's President Jair Bolsonaro in a live broadcast this Thursday, 22, the Minister of Science, Technology and Innovations, Marcos Pontes, gave details about the PDSB Versamune MCTI PDS0203 CV-19 Vaccine.
Last chance before liftoff their are some dirty MM trying to pick off any shares from impatient PDSB shareholders. Makes me confident this will be double digits soon!! Multi thousand ROI from these levels.
$PDSB
PDSB Breaking key resistance levels double digits coming this could be a potential multi hundred dollar stock. NVAX ran from $8.00 to a top of $300.00 in a few quarters PDSB has the potential to do the same.
PDSB 22 million shares outstanding 42% owned by institutions & insiders & a grade A management team. Multibillion dollar possible double digit billion market cap in the making.
When the head of MCT the Minister of Science, Technology and Innovations, Marcos Pontes, gave details about the Versamune MCTI is discussing PDSB vaccine technology to the president of Brazil yesterday. All you need is a treasure trove of shares and balls of fortitude and you can potentially make life changing gains PDSB second generation CV-19 vaccine will be the national vaccine to Brazil better equipped to handle variants and longer lasting vaccine. Imperative is other South American countries to follow suit. Know what you own Proven oncology platform Billion dollar markets in Cancer & infectious diseases..
Brazil’s ‘rapid and violent’ Covid variant devastates Latin America
https://www.theguardian.com/world/2021/apr/23/brazils-rapid-and-violent-covid-variant-devastates-latin-america
$MRNA 70 Billion market cap
$NVAX 17 Billion market cap Ran from 8:00-300.00 top on CV-19 Vaccine this year PDSB technology is superior to NVAX so is their management team!
$PDSB 125 million market cap (second generation CV-19 national vaccine for Brazil and South America. Cutting edge Oncology & infectious disease pipelines.
PDSB April 2021 Biz presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/april/PDSB_Corporate_Overview_-_April_2021.pdf
PDSB Website:
https://www.pdsbiotech.com
PDSB chart is looking spicy REKT the shorts lets send these goons to the poorhouse Slap that assk like you mean it! This stock has no biz being under $10.00
https://giphy.com/gifs/8itapp-hungry-hangry-8it-KbAbh6CbK4r5dyaZ4i
$PDSB
Alongside President Jair Bolsonaro in a live broadcast this Thursday, 22, the Minister of Science, Technology and Innovations, Marcos Pontes, gave details about the Versamune MCTI vaccine, developed by PDSB with the company Farmacore Biotecnologia , which has 100% Brazilian technology and awaits the opinion of the National Health Surveillance Agency (Anvisa) to start the testing phase in the country.
Pdsb this chart is looking spicyyy !!!! Company is about to drop some serious hammers!
International research: Brazilian COVID-19 variant much more transmissible than other strains.
https://medicalxpress.com/news/2021-04-international-brazilian-covid-variant-transmissible.html
Development of PDS0203 may offer potential advantages as a second generation COVID-19 vaccine
May be effective against multiple COVID-19 variants.
Demonstrated induction of killer CD8+ and helper CD4+ T cells that can target less variable regions of the SARS-CoV-19 virus and may be effective against currently circulating variants.
May grant long-lasting immunity. Demonstrated induction of long-lasting, virus-specific memory T-cells necessary for longer term protection.
High potential for safety
PDS0203 is a subunit vaccine, and does not require the use of attenuated viruses, traditional adjuvants, DNA or RNA. Versamune®-based vaccines have shown no serious or dose limiting reactions.
• World Renown Partners: Clinical partnerships with Merck, MD Anderson and National Cancer Institute. Country of Brazil (national CV-19 vaccine for the country of Brazil also other South American countries will have the opportunity to partner with PDSB second generation CV-19 Vaccine.
Phase 3 CV-19 second generation commencing Q4 EUA Emergency Use Authorization could come in 2022. Hundreds of millions of dollars possibly billions in revenue from PDS0203 and other revenue opportunities for its second generation Covid Vaccine in Latin America.
MRNA 65 Billion market cap vaccine last about 6 months.
NVAX 16 billion market cap vaccine hasn't been approved yet.
PDSB second generation vaccine CV-19 long last vaccine 115 million market cap.
PDSB April 2021 Biz presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/april/PDSB_Corporate_Overview_-_April_2021.pdf
PDSB Website:
https://www.pdsbiotech.com
https://giphy.com/gifs/8itapp-hungry-hangry-8it-KbAbh6CbK4r5dyaZ4i
$PDSB